Document is current
Any future updates will be listed below
-
Authors
Algabbani, Aljoharah M.
Althobiani, Malik
Alorf, Nora S.
Alonaizi, Ahmed S.
Alrwisan, Adel A.
- License Information
-
More Information
Article History
Received: 9 October 2025
Accepted: 5 March 2026
First Online: 27 April 2026
Declarations
:
: The authors declare no competing interests.
: The study was approved by Saudi Food and Drug Authority (SFDA) Institutional Review Board (Ref. No 2025_011). Very minimal risk as no intervention is involved in the study design. Subjects’ privacy and confidentiality were assured, no identifiers were collected.
